CorporateHealth International (CHI) is a healthcare services company with the mission to bring medical device innovation to scale. Our primary product is a tele-endoscopy managed service: Capsule Endoscopy (CE) to visualise the bowel with a swallowable camera and provide a full evaluation to determine bowel cancer risk, diagnose GI symptoms, and precisely decide on optimal follow-up – if any. This service can be delivered in any setting, from outpatient to self-administration.
CHI is enabling hospitals and clinics to expand their GI diagnostic capacity with minimal investments, allowing them to focus on interventions and to reach patients that are reluctant to have a standard procedure. Single payer systems such as the NHS are primary targets as decisions can be made on an overall business case calculation – as it was done in Scotland – versus waiting for new reimbursement guidelines.
Currently, CHI is the single service provider for NHS Scotland in a partnership with the CE manufacturer Medtronic, and the only commercial company to offer this managed service across Europe. NHS England is evaluating their approach to deploy CE, potentially offering CHI a broad market entry.